Mer­ck­'s Keytru­da plus TIG­IT com­bo proves less ef­fec­tive than chemo in open-la­bel lung can­cer study

3 years ago
R&D
Pharma

Three­'s com­pa­ny: Sanofi fol­lows lead of Lil­ly and No­vo, slash­es in­sulin price by 78% and caps out-of-pock­et costs

3 years ago
Pharma

SEC says Eli Lil­ly can't avoid re­quests for more in­fo on di­ver­si­ty ef­forts, abor­tion stance

3 years ago
Pharma

Vi­iV's newest cam­paign aims to nor­mal­ize sex and health dis­cus­sions to help HIV pre­ven­tion among Black women

3 years ago
Pharma
Marketing

Ab­b­Vie-spon­sored eczema doc­u­men­tary de­buts at South by South­west

3 years ago
Pharma
Marketing

Dr. Red­dy’s di­vests $33M worth of der­ma­tol­ogy brands in In­dia

3 years ago
Deals
Pharma

No­vo Nordisk sus­pend­ed from lead­ing UK trade group over obe­si­ty mar­ket­ing 'breach'

3 years ago
Pharma
Marketing

Man­u­fac­tur­ing roundup: New Hous­ton-based bio­man­u­fac­tur­ing site com­ing; UK cell and gene ther­a­py cen­ter opens

3 years ago
Manufacturing

LG Chem nets $200M con­tract to man­u­fac­ture sev­er­al vac­cines

3 years ago
Manufacturing

Con­tract man­u­fac­tur­ers BioCi­na and Genezen name new CEOs

3 years ago
People
Manufacturing

Im­munome stops Covid-19 work; Hookipa drops CMV vac­cine

3 years ago
News Briefing

Seagen qui­et­ly doles out cell ther­a­py patent rights, but scope re­mains un­clear

3 years ago
Deals
Cell/Gene Tx

'Very re­al' head­winds: With lean­er staff, can­cer vac­cine mak­er search­es for help

3 years ago
Financing
R&D

In ‘sur­prise’ move, BioX­cel files for can­cer sub­sidiary to go pub­lic

3 years ago
Financing
R&D

CMS ex­plains how it will ne­go­ti­ate the most ex­pen­sive drug prices with bio­phar­ma be­gin­ning in 2026

3 years ago
Pharma
Law

Medicxi backs siR­NA-fo­cused Alde­na Ther­a­peu­tics with $30M

3 years ago
Financing

Roy­al­ty Phar­ma nabs $475M mile­stone from Pfiz­er up­on mi­graine nasal spray OK

3 years ago
Deals

Es­pe­ri­on stock halved af­ter Dai­ichi dis­cord over $440M heart pill mile­stones

3 years ago
Financing
Deals

Oral vac­cine play­er lays off 27% of staff as it shelves Covid work

3 years ago
People
Coronavirus

Ger­man biotech launch­es with ‘seam­less’ gene edit­ing plat­form built on evolv­ing en­zymes

3 years ago
Financing
Startups

Bris­tol My­ers meets some di­ver­si­ty goals ear­ly, while miss­ing oth­ers

3 years ago
Pharma

Eli Lil­ly’s alope­cia drug Olu­mi­ant off to pos­i­tive start with doc­tors, Spher­ix re­search finds

3 years ago
Pharma
Marketing

Brook­ings pan­el of ex­perts lays out case for on­shoring man­u­fac­tur­ing

3 years ago
Pharma
Manufacturing

Up­dat­ed: Am­gen sued in fed­er­al court for al­leged­ly hid­ing $10.7B IRS bill from in­vestors

3 years ago
Pharma
Law
First page Previous page 373374375376377378379 Next page Last page
A service from the Financial Times